Special items: Ovarian Cancer and Us blog best viewed in Firefox

Tuesday, January 03, 2012

Follow-up with CA125 after primary therapy of advanced ovarian cancer: in favor of continuing to prescribe CA125 during follow-up

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.